NPCE

$0.00

(

0.00%

)
Quote details

stock

Neuropace Inc

NASDAQ | NPCE

10.55

USD

$0.00

(

0.00%

)

At Close (As of Oct 23, 2025)

$358.60M

Market Cap

-

P/E Ratio

-0.82

EPS

$18.98

52 Week High

$5.45

52 Week Low

HEALTHCARE

Sector

NPCE Chart

Recent Chart
Price Action

NPCE Technicals

Tags:

NPCE Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $59M
Total Revenue $80M
Cost Of Revenue $21M
Costof Goods And Services Sold $21M
Operating Income -$22M
Selling General And Administrative $57M
Research And Development $24M
Operating Expenses $81M
Investment Income Net -
Net Interest Income -$5.8M
Interest Income $3M
Interest Expense $8.8M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.8M
Income Before Tax -$27M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$27M
Comprehensive Income Net Of Tax -
Ebit -$18M
Ebitda -$17M
Net Income -$27M

Revenue & Profitability

Earnings Performance

NPCE Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $95M
Total Current Assets $81M
Cash And Cash Equivalents At Carrying Value $13M
Cash And Short Term Investments $13M
Inventory $13M
Current Net Receivables $13M
Total Non Current Assets $13M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $39M
Other Current Assets $2.4M
Other Non Current Assets -
Total Liabilities $87M
Total Current Liabilities $15M
Current Accounts Payable $3M
Deferred Revenue -
Current Debt -
Short Term Debt $3.7M
Total Non Current Liabilities $71M
Capital Lease Obligations $14M
Long Term Debt $60M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $73M
Other Current Liabilities $7.9M
Other Non Current Liabilities -
Total Shareholder Equity $8M
Treasury Stock -
Retained Earnings -$531M
Common Stock $30K
Common Stock Shares Outstanding $29M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$18M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.8M
Capital Expenditures $306K
Change In Receivables -
Change In Inventory $251K
Profit Loss -
Cashflow From Investment $9M
Cashflow From Financing $4.3M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$27M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $59M
Total Revenue $80M
Cost Of Revenue $21M
Costof Goods And Services Sold $21M
Operating Income -$22M
Selling General And Administrative $57M
Research And Development $24M
Operating Expenses $81M
Investment Income Net -
Net Interest Income -$5.8M
Interest Income $3M
Interest Expense $8.8M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.8M
Income Before Tax -$27M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$27M
Comprehensive Income Net Of Tax -
Ebit -$18M
Ebitda -$17M
Net Income -$27M

NPCE News

NPCE Profile

Neuropace Inc Profile

Sector: HEALTHCARE

Industry: MEDICAL DEVICES

NeuroPace, Inc., based in Mountain View, California, is a leader in neuromodulation innovation dedicated to addressing neurological disorders, particularly epilepsy. The company's flagship RNS System delivers responsive brain stimulation to significantly reduce seizures in patients resistant to traditional therapies. As NeuroPace advances its commitment to improving patient outcomes and expands its market reach, it presents a compelling opportunity for institutional investors interested in the evolving medical device sector. With a strong emphasis on technological development and a robust growth trajectory, NeuroPace is positioned to make a significant impact in the healthcare landscape.

YYAI
-50.60%
$0.09
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
YDKG
+5.58%
$0.07
F
-0.72%
$12.34
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
RGTI
+9.80%
$39.59
AIRE
+38.18%
$0.98
RIG
+13.74%
$3.89
TSLA
+2.28%
$448.98
VTYX
+70.98%
$6.60
NOK
+11.17%
$6.17
BURU
-5.27%
$0.34
QBTS
+13.81%
$31.06
NVDA
+1.04%
$182.16
T
-3.63%
$24.62
INTC
+3.35%
$38.15
MSAI
+101.73%
$1.35
ADAP
-3.44%
$0.07
AAL
+5.62%
$12.77
WTO
-7.04%
$0.06
IONZ
-14.59%
$3.98
BITF
+4.39%
$4.11
AREB
+75.34%
$3.77
AXDX
-61.36%
$0.03
IONQ
+7.06%
$59.37
DNN
+0.18%
$2.72
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
SMCI
-8.72%
$47.92
QUBT
+7.19%
$15.94
TLRY
+2.06%
$1.48
VZ
-3.51%
$38.40
GRAB
+1.77%
$5.72
SOFI
+3.27%
$28.08
RGTZ
-20.27%
$14.90
RBNE
+7.87%
$1.37
JOBY
+1.29%
$15.67
BBD
+1.51%
$3.35
RF
-0.04%
$24.10
VIVK
+5.68%
$0.26
CAN
+3.22%
$1.76
ETHD
-3.17%
$3.97
ACHR
+0.46%
$10.91
QS
+7.95%
$14.66
RMBL
+60.50%
$3.21
SGBX
+29.82%
$2.96
AMD
+2.06%
$234.99
ADD
-25.47%
$0.05
BTG
+0.38%
$5.23
VLY
+4.24%
$10.56
GPUS
-0.28%
$0.38
PLTR
+2.84%
$180.48
LAES
+5.92%
$5.72
RXRX
-0.34%
$5.73
SRM
+53.27%
$10.30
PFE
-0.20%
$24.67
TNGX
-12.24%
$7.60
BTBT
+3.62%
$3.72
AAPL
+0.43%
$259.58
AMC
-0.72%
$2.73
UUUU
-6.50%
$21.26
CIFR
+7.10%
$17.25
MARA
+0.36%
$19.22
WBD
+3.50%
$21.25
ONDS
+5.56%
$7.11
DVLT
+5.14%
$2.25
AMZN
+1.44%
$221.09
HPE
+0.43%
$23.19
NIO
+0.73%
$6.89
IREN
+7.77%
$55.86
IBIO
-8.63%
$1.27
CUTR
-10.19%
$0.09
KMI
-4.75%
$26.25
NVTS
+0.03%
$13.61
PBR
+0.93%
$11.84
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
LUV
-6.25%
$31.65
RR
+7.11%
$5.42
TE
-9.73%
$3.71
ETWO
0.00%
$3.30
SCWO
+32.07%
$0.48
SNAP
+1.28%
$7.87
RIVN
+1.31%
$13.09
BAC
+1.29%
$51.76
BTE
+5.28%
$2.39
APLD
+9.01%
$33.38
DNUT
+1.98%
$4.11
HOOD
+5.58%
$134.33
LUMN
+10.58%
$7.78
VALE
-0.52%
$11.46
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
ERIC
-0.31%
$9.48
CLSK
+4.80%
$17.67
KDLY
+10.41%
$0.79
NAKA
+10.41%
$0.79
SMR
+8.17%
$37.56
YYAI
-50.60%
$0.09
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
YDKG
+5.58%
$0.07
F
-0.72%
$12.34
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
RGTI
+9.80%
$39.59
AIRE
+38.18%
$0.98
RIG
+13.74%
$3.89
TSLA
+2.28%
$448.98
VTYX
+70.98%
$6.60
NOK
+11.17%
$6.17
BURU
-5.27%
$0.34
QBTS
+13.81%
$31.06
NVDA
+1.04%
$182.16
T
-3.63%
$24.62
INTC
+3.35%
$38.15
MSAI
+101.73%
$1.35
ADAP
-3.44%
$0.07
AAL
+5.62%
$12.77
WTO
-7.04%
$0.06
IONZ
-14.59%
$3.98
BITF
+4.39%
$4.11
AREB
+75.34%
$3.77
AXDX
-61.36%
$0.03
IONQ
+7.06%
$59.37
DNN
+0.18%
$2.72
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
SMCI
-8.72%
$47.92
QUBT
+7.19%
$15.94
TLRY
+2.06%
$1.48
VZ
-3.51%
$38.40
GRAB
+1.77%
$5.72
SOFI
+3.27%
$28.08
RGTZ
-20.27%
$14.90
RBNE
+7.87%
$1.37
JOBY
+1.29%
$15.67
BBD
+1.51%
$3.35
RF
-0.04%
$24.10
VIVK
+5.68%
$0.26
CAN
+3.22%
$1.76
ETHD
-3.17%
$3.97
ACHR
+0.46%
$10.91
QS
+7.95%
$14.66
RMBL
+60.50%
$3.21
SGBX
+29.82%
$2.96
AMD
+2.06%
$234.99
ADD
-25.47%
$0.05
BTG
+0.38%
$5.23
VLY
+4.24%
$10.56
GPUS
-0.28%
$0.38
PLTR
+2.84%
$180.48
LAES
+5.92%
$5.72
RXRX
-0.34%
$5.73
SRM
+53.27%
$10.30
PFE
-0.20%
$24.67
TNGX
-12.24%
$7.60
BTBT
+3.62%
$3.72
AAPL
+0.43%
$259.58
AMC
-0.72%
$2.73
UUUU
-6.50%
$21.26
CIFR
+7.10%
$17.25
MARA
+0.36%
$19.22
WBD
+3.50%
$21.25
ONDS
+5.56%
$7.11
DVLT
+5.14%
$2.25
AMZN
+1.44%
$221.09
HPE
+0.43%
$23.19
NIO
+0.73%
$6.89
IREN
+7.77%
$55.86
IBIO
-8.63%
$1.27
CUTR
-10.19%
$0.09
KMI
-4.75%
$26.25
NVTS
+0.03%
$13.61
PBR
+0.93%
$11.84
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
LUV
-6.25%
$31.65
RR
+7.11%
$5.42
TE
-9.73%
$3.71
ETWO
0.00%
$3.30
SCWO
+32.07%
$0.48
SNAP
+1.28%
$7.87
RIVN
+1.31%
$13.09
BAC
+1.29%
$51.76
BTE
+5.28%
$2.39
APLD
+9.01%
$33.38
DNUT
+1.98%
$4.11
HOOD
+5.58%
$134.33
LUMN
+10.58%
$7.78
VALE
-0.52%
$11.46
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
ERIC
-0.31%
$9.48
CLSK
+4.80%
$17.67
KDLY
+10.41%
$0.79
NAKA
+10.41%
$0.79
SMR
+8.17%
$37.56

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.